BY ARNOLD G. LEVY, MD | MARCH 2019
A part of the equation to more effectively close the loop and actively include the patient in the process requires having the right technology in place.
The overarching goals of population health are to improve the overall well-being of a designated population while lowering costs. "Burden and Costs of Gastrointestinal Disease in the U.S.,” an October 2018 column in NEJM Journal Watch, estimates direct and indirect spending on GI diseases in the US to be $136 billion per year, with many procedures and surgeries costing patients hundreds or even thousands of dollars. A crucial part of lowering costs, therefore, is dependent on expanding the delivery of preventive care.
To read this article, you have to be a member of ASCA or subscribe to ASC Focus magazine.
Already a member or subscriber? Log in.
To become a member, click here. To subscribe to ASC Focus, click here.